Panelists Announced for Decision Resources Group One-day Biologics and Biosimilars Seminar in San Diego
Discussion Focuses on Key Market Access Issues Affecting the Success of Biologics and Biosimilars
BURLINGTON, Mass., April 18, 2013 /PRNewswire/ -- Decision Resources Group is pleased to announce a distinguished lineup of speakers who will be joining its well-regarded Competitive Landscape Seminar Series focusing on Biologics and Biosimilars on May 2, 2013 at the Hotel Solamar in San Diego, CA. The panel discussion will focus on the key issues affecting the success of the biologics and biosimilars market. Panelists will share their thoughts on market access for biosimilars, the role of indication extrapolation and automatic substitution, as well as their perspective on appropriate pricing models for brands and biosimilars as this dynamic market segment continues to evolve.
Moderated by Andrew Merron, Ph.D., Senior Director, Biosimilars Research, BioTrends Research Group, panelists include:
- John L. Fox, M.D., M.H.A., Associate Vice President of Medical Affairs, Priority Health, Michigan
- Kjel A. Johnson, Senior Vice President, Strategy and Business Development at Magellan Pharmacy Services
- Atheer A. Kaddis, Pharm.D., Senior Vice President, Sales and Business Development at Diplomat Specialty Pharmacy
Panelists will focus on the key issues affecting the biologics landscape and the emerging biosimilars sector based on the European experience of biosimilars to date and expectations for the U.S. Topics to be discussed will include the anticipated future trends in the biologics market and the challenges and drivers of biosimilar adoption in the U.S.
This Decision Resources Group Competitive Landscape Seminar is a one-day strategic informational event covering key issues in the biologics and biosimilars market and will include presentations from six prominent DRG analysts. The seminar is intended for pharmaceutical professionals involved in market research, business development and competitive intelligence. Attendees are invited to engage with analysts and peers with a post-event reception.
For more information and to register, please visit:
Media interested in attending the seminar should contact Roy Strunin at firstname.lastname@example.org or 781-993-2515 for additional information.
About the Competitive Landscape Seminar Series
The Competitive Landscape Seminar Series: Biologics and Biosimilars will be held on May 2, 2013. This high-value, one-day seminar has been developed specifically for biopharmaceutical market research executives as well as biologics and biosimilars product teams. Expert analysts from Decision Resources Group companies—Decision Resources and BioTrends Research Group—will share their latest research findings on key biologics and biosimilars trends.
About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.
SOURCE Decision Resources Group
More by this Source
Surveyed European Neurologists Expect to Prescribe Biogen Idec's Tecfidera to 16 Percent of their Diagnosed Relapsing-Remitting Multiple Sclerosis Patients in the Next 12 Months
Apr 15, 2014, 13:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.